Leflunomide in systemic onset juvenile idiopathic arthritis
- First Online:
- Cite this article as:
- Jahan, A., Dewan, V. & Yadav, T.P. Indian Pediatr (2012) 49: 750. doi:10.1007/s13312-012-0139-9
- 88 Downloads
Methotrexate, the mainstay of treatment in Juvenile idiopathic arthritis, might not be effective in a few patients of polyarticular and systemic onset juvenile idiopathic arthritis. Use of biologicals like TNF-α blockers, the next line of preferred drugs is constrained by the high cost. We successfully used leflunomide in four patients.